-

$undefined

N/A

(N/A)

Molecular Partners NASDAQ:MOLN

Location: Wagistrasse 14, Zuerich, 8952, Switzerland | Website: https://www.molecularpartners.com/ | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

14.51M

Cash

143.6M

Avg Qtr Burn

-15.51M

Short % of Float

0.97%

Insider Ownership

0.00%

Institutional Own.

10.80%

Qtr Updated

09/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
MP0533 (CD33-CD123-CD70) Details High risk myelodysplastic syndromes , Relapsed/refractory acute myeloid leukemia, Acute myeloid leukemia	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MP0317 (FAP X CD40) Details Solid tumor/s	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Ensovibep Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.